会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • READMISSION RISK SCORES
    • 阅读风险评分
    • WO2017066786A1
    • 2017-04-20
    • PCT/US2016/057392
    • 2016-10-17
    • CAREFUSION 303, INC.
    • NUNEZ, CarlosTABAK, YingSUN, XiaowuGUPTA, VikasJOHANNES, Richard
    • G06F19/00
    • G06F19/3431G06F19/00G06F19/325G16H40/63G16H50/20G16H50/30
    • Systems for use with a medical device for reducing medical facility readmission risks are provided. In one aspect, a system includes a medical device that is configurable with operating limit parameters for providing testing or treatment to a patient, and a limiting system. The limiting system includes a memory that includes patient-specific information for the patient and a database that includes readmission risk information, and a processor. The processor is configured to compare readmission risk parameters with the patient-specific information, and provide a readmission risk score for integration with medical devices and processes corresponding to the patient. Methods and machine-readable media are also provided.
    • 提供了用于减少医疗设施再入风险的医疗设备的系统。 在一个方面,一种系统包括可配置有用于向患者提供测试或治疗的操作限制参数的医疗设备,以及限制系统。 限制系统包括存储器和处理器,存储器包括患者的患者特定信息和包括再入院风险信息的数据库。 处理器被配置为将再入院风险参数与患者特定信息进行比较,并且提供用于与对应于患者的医疗设备和过程整合的再入院风险评分。 还提供了方法和机器可读介质。
    • 4. 发明申请
    • CARE COORDINATION SYSTEMS AND METHODOLOGIES
    • 关心协调系统和方法学
    • WO2016164871A1
    • 2016-10-13
    • PCT/US2016/026852
    • 2016-04-10
    • MASTODON, LLC
    • DUKE, David, O.DUKE, JanetJAUREGUI, JoeNUSSEAR, Ken
    • G06F19/00G06Q50/00G06Q50/22
    • G06F19/3425G06F19/00G06F19/3431G16H50/30G16H80/00
    • A system provides an interface which includes a plurality of rows associated with patients, and a plurality of data columns for different departments that provide a holistic overview of action items for the different departments. Cells in the data columns can be manipulated, e.g. by selection of an option in a dropdown menu for the cell, to request an action of a corresponding department, or to indicate completion of a task by the corresponding department. Input into a cell can also automatically trigger changing of data or color coding in another cell for the patient. Color coding is utilized to allow viewers to quickly assimilate information from a displayed interface of the system. A number of calculations are performed based on input and/or imported data. For example, a value or color coding may be altered based on a calculated risk of readmission score.
    • 系统提供包括与患者相关联的多个行的界面,以及用于不同部门的多个数据列,其提供针对不同部门的动作项目的整体概述。 可以操纵数据列中的单元格。 通过选择单元格的下拉菜单中的选项,请求相应部门的操作,或指示相应部门完成任务。 单元格中的输入也可以自动触发患者另一个单元格中的数据或颜色编码的更改。 彩色编码被用于允许观看者快速地从显示的系统的界面中吸收信息。 基于输入和/或导入的数据执行一些计算。 例如,值或颜色编码可以基于计算的再入院评分的风险而改变。
    • 8. 发明申请
    • METHOD FOR DETERMINING THE RISK PROFILE OF NEOPLASTIC TISSUE
    • 确定肿瘤组织风险概况的方法
    • WO2015130953A9
    • 2015-11-19
    • PCT/US2015017796
    • 2015-02-26
    • NOVAZOI THERANOSTICS INC
    • ANEJA RITURIDA PADMASHREE C G
    • C12Q1/00G01N33/50G06F19/10
    • G06F19/18A61K31/343A61K31/365A61K31/473G01N33/57407G01N33/57415G01N33/57438G01N33/57496G01N33/582G06F19/20G06F19/3431G16H50/30
    • A method of computing the risk profile of a neoplastic tissue in a patient is disclosed. The method includes the steps of (a) processing a sample of tumor tissue or cancer cells from the patient in a form suitable for visualization and demarcation of cell nuclei, individually distinguishable centrosomes (iCTRs) and megacentrosomes (mCTRs) in a region of interest (ROI) defined by a plurality of cell nuclei; (b) determining the numbers of iCTRs and mCTRs associated with each cell nucleus in the ROI; (c) determining the volume of each iCTR and mCTR in the ROI; and (d) calculating one or more centrosome amplification scores (CASs) values for the sample based on steps (b) and (c), wherein the one or more CASs indicate the severity of centrosome amplification, the frequency of centrosome amplification, or both, and wherein the one or more scores provide a measure of a level of risk and/or a prognosis associated with the neoplastic tissue.
    • 公开了一种计算患者瘤组织的风险概况的方法。 该方法包括以下步骤:(a)以适于可视化和划分细胞核的形式处理来自患者的肿瘤组织或癌细胞的样品,在感兴趣的区域中单独区分的中心体(iCTR)和巨嗜细胞中心体(mCTR) ROI)由多个细胞核定义; (b)确定与ROI中每个细胞核相关的iCTR和mCTR的数量; (c)确定ROI中每个iCTR和mCTR的体积; (d)基于步骤(b)和(c)计算样品的一个或多个中心体放大分数(CAS)值,其中所述一个或多个CAS表示中心体扩增的严重性,中心体扩增的频率或两者 并且其中所述一个或多个评分提供与所述肿瘤组织相关的风险水平和/或预后的度量。